Study on Lymphatic Pump Osteopathic Manipulative Therapy to Reduce Symptoms and Duration of Respiratory Illness in Older Adults
Led by Geisinger Clinic · Updated on 2026-08-11
68
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating whether Osteopathic Manipulative Therapy OMT, specifically the lymphatic pump technique, can help reduce symptoms and shorten the duration of respiratory illnesses such as upper respiratory illness, sinusitis, bronchitis, and pneumonia. This study focuses on patients aged 65 to 100 years and evaluates if adding OMT to standard care can improve patient outcomes compared to standard care alone. Respiratory illnesses commonly cause discomfort, reduced productivity, and missed work, and OMT is a low-cost treatment used to support immune response and fluid movement.
Participants will be randomly assigned to one of two groups one receiving standard care alone, which may include medications and follow-up instructions, and the other receiving standard care plus the lymphatic pump OMT. This OMT procedure involves manual pressure and physical stimulation over various body regions such as the head, neck, thoracic, lumbar, sacral, pelvis, arms, legs, and abdomen to stimulate immune response and help clear infections. The study will take place in an outpatient setting, with patients being treated and monitored accordingly.
During the study, participants will complete electronic surveys on the day of diagnosis and five days later to report symptoms like cough, congestion, and overall malaise. These symptom reports will be securely stored and analyzed to assess changes in severity and illness duration. The primary goal is to determine how much the lymphatic pump OMT can improve symptoms and reduce sickness length when added to standard care. The study will follow participants for up to one year, with careful monitoring of symptom progression and treatment effects.
CONDITIONS
Brief Title
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
Research Team
M
Margaret Moore, DO
A
Andrew Ackerman, MS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Lymphatic Pump OMT Plus Standard Care
Standard Care Alone
What it is
Participants receive standard outpatient care for respiratory illness along with Lymphatic Pump Osteopathic Manipulative Therapy (OMT), which is a hands-on physical technique aimed at promoting lymphatic flow and supporting immune function.
Participants receive the standard outpatient treatment usually provided for respiratory illnesses such as bronchitis, sinusitis, or pneumonia, without any additional osteopathic manipulative therapy.
Role in the trial
Tests the benefit of adding Lymphatic Pump OMT to standard care for respiratory illness.
Serves as the control group to compare the effect of adding OMT.
Primary use
To evaluate if adding Lymphatic Pump OMT to standard care helps reduce respiratory symptom severity and duration in older adults.
To manage respiratory symptoms such as cough, congestion, and infection through well-established outpatient medical care.
How it is given or performed
Participants receive hands-on Lymphatic Pump OMT administered by a trained practitioner in addition to standard care, which involves manual stimulation of the head, neck, chest, pelvis, and limbs to promote lymphatic circulation.
Participants follow typical outpatient care procedures for respiratory illness, as directed by their healthcare provider.
Evidence status
Published clinical trials of OMT as an adjunct for pneumonia in older adults show mixed results, with some studies reporting improved pneumonia outcomes such as shorter hospital stays, but no consistent effect on mortality.
Standard outpatient care for respiratory infections is the established practice, but it may not shorten illness duration in older adults with mild-to-moderate illness.
Important limitations
The benefit of adjunctive OMT is uncertain, with evidence from clinical studies limited by small sample sizes and mixed outcomes. It requires access to trained practitioners and may not be widely available.
Standard care alone may not address symptom severity for all older adults and does not directly target lymphatic or immune stimulation. Effectiveness can depend on guideline adherence and patient health.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 65Years - 100Years
All Genders
Eligibility Criteria
You may qualify if you...
Patients seen for respiratory illness symptoms at Geisinger 65-Forward Buckhorn, PA clinic
Age between 65 and 100 years
New diagnosis of upper respiratory illness, sinusitis, bronchitis, or pneumonia during outpatient visit
You will not qualify if you...
Healing fracture in the spine, pelvis, shoulder, ribs, vertebrae, or limbs
Actively receiving any type of cancer treatment
Active or previously diagnosed liver disease
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Up to one year
Participants receive either standard care alone or standard care plus lymphatic pump Osteopathic Manipulative Therapy for their respiratory illness.
Electronic surveys on the day of diagnosis and 5 days later
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Clinical Study on Pneumonia Patients in Respiratory Intensive Care Unit
Study to Map the HLA Genetic Region and Its Possible Links to Diseases in the Greek Population
Phase 2 Study of Intravenous agenT-797 Plus Standard Care Compared to Placebo in Adults with Severe Pneumonia and Moderate to Severe Acute Hypoxemic Respiratory Failure
Evaluation of a New Portable CPAP Device for Non-invasive Respiratory Support in Elderly and Respiratory-Impaired Patients
Study to Validate Inflammacheck Breath Test for Detecting Lung Cancer and Other Respiratory Diseases
Using AI to Analyze Breath Biomarkers in Adults with Lung Conditions or Healthy Volunteers
Optimizing Piperacillin-Tazobactam Infusion Schedules for Pneumonia Treatment in Patients Aged 65 to 100
Evaluating How the 20-Valent Pneumococcal Vaccine Works to Prevent Pneumonia in Adults 65 and Older Hospitalized with Suspected Pneumonia
Acutelines Biobank to Improve Early Detection and Personalized Treatment of Acute Diseases
Tracking Patient Outcomes from Emergency Admissions
Pilot Study of an Electronic Clinical Decision Support Tool for Pneumonia Care in Utah Urgent Care Clinics
Using AI-Enhanced Chest Imaging Analysis
Evaluating an Early Diagnostic Blood Test to Differentiate Bacterial and Viral Respiratory Infections in Adults at the Emergency Department
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Multicenter Osteopathic Pneumonia Study in the Elderly: Subgroup Analysis on Hospital Length of Stay, Ventilator-Dependent Respiratory Failure Rate, and In-hospital Mortality Rate.